Moscow, Russia

Alexander N Lukashev

This inventor holds 1 USPTO granted patent. Top assignee: Mitotech Sa. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander N Lukashev. Retrieved from https://idiyas.com/inventor/alexander-n-lukashev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander N Lukashev: Innovator in Pharmaceutical Formulations

Introduction

Alexander N Lukashev is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of mitochondrially targeted antioxidants. His work focuses on developing methods to prevent the activation of neutrophils, which play a crucial role in inflammatory responses.

Latest Patents

Lukashev holds a patent for "Pharmaceutical formulations containing mitochondrially targeted antioxidants." This patent outlines methods for preventing or treating various inflammatory diseases and inflammation-related conditions using mitochondrially targeted antioxidants (MTAs). His innovative approach aims to enhance therapeutic outcomes in patients suffering from these conditions.

Career Highlights

Lukashev is associated with Mitotech SA, a company dedicated to advancing mitochondrial medicine. His expertise in pharmaceutical formulations has positioned him as a key figure in the development of novel treatments aimed at improving patient health outcomes.

Collaborations

Lukashev has collaborated with notable colleagues, including Maxim Vladimirovich Skulachev and Vladimir Petrovich Skulachev. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of mitochondrial medicine.

Conclusion

Alexander N Lukashev's contributions to pharmaceutical formulations and his innovative approaches to treating inflammatory diseases highlight his importance in the field. His work continues to pave the way for advancements in mitochondrial medicine, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…